GPX4 mRNA expression was substantially associated with the prognosis of COAD, Glioma, Liver hepatocellular carcinoma, and other cancers, as determined using the Sangerbox database (Fig. S1A). This evidence concerns the gene GPX4 and colon adenocarcinoma.